[(2R,3S)-3-amino-2-[[4-(2,5-difluorophenyl)cyclohexyl]oxymethyl]piperidin-1-yl]-cyclopropylmethanone
C22H30F2N2O2 — CID 166854238
Data last refreshed: (MolForge compound catalog, from PubChem)
About [(2R,3S)-3-amino-2-[[4-(2,5-difluorophenyl)cyclohexyl]oxymethyl]piperidin-1-yl]-cyclopropylmethanone
[(2R,3S)-3-amino-2-[[4-(2,5-difluorophenyl)cyclohexyl]oxymethyl]piperidin-1-yl]-cyclopropylmethanone (PubChem CID 166854238) has the molecular formula C22H30F2N2O2 and a molecular weight of 392.49 g/mol. Its IUPAC name is [(2R,3S)-3-amino-2-[[4-(2,5-difluorophenyl)cyclohexyl]oxymethyl]piperidin-1-yl]-cyclopropylmethanone.
Molecular Properties
| Compound Name | [(2R,3S)-3-amino-2-[[4-(2,5-difluorophenyl)cyclohexyl]oxymethyl]piperidin-1-yl]-cyclopropylmethanone |
|---|---|
| PubChem CID | 166854238 |
| Molecular Formula | C22H30F2N2O2 |
| Molecular Weight | 392.49 g/mol |
| Exact Mass | 392.23 |
| IUPAC Name | [(2R,3S)-3-amino-2-[[4-(2,5-difluorophenyl)cyclohexyl]oxymethyl]piperidin-1-yl]-cyclopropylmethanone |
| SMILES | N[C@H]1CCCN(C(=O)C2CC2)[C@H]1COC1CCC(c2cc(F)ccc2F)CC1 |
| InChI | InChI=1S/C22H30F2N2O2/c23-16-7-10-19(24)18(12-16)14-5-8-17(9-6-14)28-13-21-20(25)2-1-11-26(21)22(27)15-3-4-15/h7,10,12,14-15,17,20-21H,1-6,8-9,11,13,25H2/t14?,17?,20-,21-/m0/s1 |
| InChIKey | BTNCIPHLLHGZBZ-VECJGYGSSA-N |
| XLogP | 3.74 |
| TPSA | 55.56 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 3 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 28 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 392.49 |
| LogP ≤ 5 | 3.74 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 3 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 166854238 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.